|
MRI study of chemobrain in pediatric oncology patients |
1 R01 CA244768-01 |
DUONG, TIMOTHY Q |
NCI |
2020 |
|
Mesenchymal Stem Cells to Repair Chemobrain |
5R01CA208371-05 |
HEIJNEN, COBI J |
NCI |
2020 |
|
Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL |
5R01CA220568-03 |
COLE, PETER D |
NCI |
2020 |
|
PREDICTING LONG-TERM CHEMOTHERAPY-RELATED COGNITIVE IMPAIRMENT |
1R01CA226080-01A1 |
KESLER, SHELLI R |
NCI |
2019 |
|
HOME-BASED VIRTUAL REALITY SYSTEM FOR THE TREATMENT OF CHEMOTHERAPY-RELATED COGNITIVE IMPAIRMENTS |
1R43CA232936-01A1 |
KIM, NAM H. |
NCI |
2019 |
|
VERY-LONG TERM NEUROCOGNITIVE OUTCOMES IN BREAST CANCER SURVIVORS |
3R01CA172145-06S1 |
PALESH, OXANA G |
NCI |
2019 |
|
IDENTIFYING CHILDREN WITH SUBCLINICAL NEUROCOGNITIVE DECLINE AND SUSCEPTIBILITY TO OXIDATIVE DAMAGE DURING THE EARLY MONTHS OF THERAPY FOR ALL |
5R01CA220568-02 |
COLE, PETER D |
NCI |
2019 |
|
IDENTIFYING CHILDREN WITH SUBCLINICAL NEUROCOGNITIVE DECLINE AND SUSCEPTIBILITY TO OXIDATIVE DAMAGE DURING THE EARLY MONTHS OF THERAPY FOR ALL |
1R01CA220568-01A1 |
COLE, PETER D |
NCI |
2018 |
|
MACHINE LEARNING MODEL VALIDATION FOR AD/ADRD |
3U24CA224370-01S1 |
OPREA, TUDOR I |
NCI |
2018 |
|
MULTI-MODAL IMAGING OF PSYCHOSTIMULANT EFFECTS ON EXECUTIVE FUNCTION POST-RRSO |
1R01CA215587-01 |
EPPERSON, C. NEILL NEILL |
NCI |
2017 |